The politics of medicine and the global governance of pandemic influenza

International Journal of Health Services

Volumn 43, Issue 1, 2013, Pages 105-121

  Kamradt Scott, Adam ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

DRUG DEVELOPMENT; EDUCATIONAL ATTAINMENT; GOVERNANCE APPROACH; HEALTH CARE; INFLUENZA; MEDICINE; STATE ROLE; VACCINE;

ARTICLE; HEALTH; HEALTH CARE POLICY; HISTORY; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; PANDEMIC; POLITICS; WORLD HEALTH ORGANIZATION;

HEALTH POLICY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS; POLITICS; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84873574364     PISSN: 00207314     EISSN: 15414469     Source Type: Journal    
DOI: 10.2190/HS.43.1.h     Document Type: Article

References (76)

1. World Health Organization. Influenza-like illness in the United States and Mexico. April 24, 2009. www.who.int/csr/don/2009-04-24/en/index.html (accessed February 17, 2011).
2. World Health Organization. Swine influenza. Statement by WHO Director-General, Dr. Margaret Chan. 25, April 2009. www.who.int/csr/don/2009- 04-25/en/index.html (accessed February 17, 2011).
3. Williams, S., Martin, P., and Gabe, J. The pharmaceuticalisation of society? A framework for analysis. Sociol. Health Illn. 33(5):710-725, 2011.
4. Kitler, M., Gavinio, P., and Lavanchy, D. Influenza and the work of the World Health Organization. Vaccine 20(Suppl. 2):S5-S14, 2002.
5. Payne, A. The Influenza Programme of WHO. Bull. World Health Organ. 8(5-6): 755-792, 1953.
6. Jensen, K., and Hogan, R. Laboratory diagnosis of Asian influenza. Public Health Rep. (1896-1970) 73(2):140-144, 1958.
7. Pereira, M. S. Global surveillance of influenza. Brit. Med. Bull. 35(1):9-14, 1979.
8. World Health Organization. WHO Global Influenza Surveillance Network. 2011. www.who.int/csr/disease/influenza/surveillance/en/index.html (accessed February 18, 2011).
9. World Health Organization. Global Influenza Surveillance and Response System (GISRS). Geneva, 2011. http://www.who.int/influenza/gisrs
10. Kamradt-Scott, A., and Lee, K. The 2011 Pandemic Influenza Preparedness Framework: Global health secured or a missed opportunity? Polit. Stud. 59(4):831-847, 2011.
11. Brady, F. Central technical services of the World Health Organization. Public Health Rep. (1896-1970) 72(2):101-104, 1957.
12. Smith, W., Andrewes, C., and Laidlaw, P. A virus obtained from influenza patients. Lancet, 222(5732):66-68, 1933.
13. Anonymous. Profile: Dr. C. H. Andrewes: A life's work on virus research. New Scientist 7(182):1200-1201, 1960.
14. World Health Organization. Expert Committee on Influenza: First Report. World Health Organization Technical Report Series No. 64. Geneva, 1953. whqlibdoc. who.int/trs/WHO-TRS-64.pdf (accessed February 17, 2011).
15. Francis, T., and Magill, T. P. Immunological studies with the virus of influenza. J. Exp. Med. 62(4):505-516, 1935.
16. Francis, T. A consideration of vaccination against influenza. The Milbank Memorial Fund Q. 25(1):5-6, 1947.
17. Committee on Clinical Trials of Influenza Vaccine. Clinical Trials of Influenza Vaccines: Third Progress Report to the Medical Research Council by its Committee on Clinical Trials of Influenza Vaccine. BMJ 2(5035):1-7, 1957.
18. Quilligan, J., Francis, T., and Minuse, E. Reactions to an influenza virus vaccine in infants and children. Amer. J. Dis. Child. 78(3):295-301, 1949.
19. Davenport, F. The search for the ideal influenza vaccine. Postgrad. Med. J. 55(640): 78-86, 1979.
20. World Health Organization. Expert Committee on Respiratory Viruses: First Report. World Health Organization Technical Report Series No. 170. Geneva, 1959. whqlibdoc.who.int/trs/WHO-TRS-170.pdf (accessed February 18, 2011).
21. Stewart, W. Administrative history of the Asian influenza program. Public Health Rep. (1896-1970) 73(2):101-113, 1958.
22. Roden, A. Influenza as a national problem. Postgrad. Med. J. 39(456):612-618, 1963.
23. World Health Organization. Respiratory Viruses: Report of a WHO Scientific Group. Technical Report Series No. 408. Geneva, 1969. whqlibdoc.who.int/trs/WHO-TRS- 408.pdf (accessed February 21, 2011).
24. Hota, S., and McGeer, A. Antivirals and the control of influenza outbreaks. CID 45(10):1362-1368, 2007.
25. Ruben, F. Prevention and control of influenza: Role of vaccine. Amer. J. Med. 82(6Suppl. 1):31-34, 1987.
26. International Monetary Fund. The Global Economic and Financial Impact of an Avian Flu Pandemic and the Role of the IMF. Washington, DC, 2006. www.imf.org/external/pubs/ft/afp/2006/eng/022806.pdf (accessed February 24, 2011).
27. World Health Organization. WHO Influenza Pandemic Preparedness Checklist. Geneva, 2004. www.wpro.who.int/internet/resources.ashx/CSR/Publications/WHO+ Influenza+Pandemic+Preparedness+Checklist.pdf (accessed February 24, 2011).
28. Dutta, A. The Effectiveness of Policies to Control a Human Influenza Pandemic: A Literature Review. Policy Research Working Paper 4524. World Bank, Washington, DC, 2008.
29. World Health Organization. Global pandemic influenza action plan to increase vaccine supply. Geneva, 2006. www.who.int/vaccines-documents/DocsPDF06/ 863.pdf (accessed February 24, 2011).
30. Davidoff, F., Haynes, B., Sackett, D., and Smith, R. Evidence-based medicine. BMJ 310(6987):1085-1086, 1995.
31. Sackett, D., and Rosenberg, W. The need for evidence-based medicine. J. R. Soc. Med. 88:620-624, 1995.
32. Smith, A. Mad cows and ecstasy: Chance and choice in an evidence-based society. J. R. Stat. S.: Series A 159(3):367-383, 1996.
33. Tonelli, M. The philosophical limits of evidence-based medicine. Acad. Med. 73(12): 1234-1240, 1998.
34. Mykhalovskiy, E., and Weir, L. The problem of evidence-based medicine: Directions for social science. Soc. Sci. Med. 59(5):1059-1069, 2004.
35. Lipman, T. Power and influence in clinical effectiveness and evidence-based medicine. Family Practice, 17(6):557-563, 2000.
36. Maynard, A. Evidence-based medicine: An incomplete method for informing treatment choices. Lancet 349(9045):126-128, 1997.
37. Goodman, K. Ethics and Evidence-Based Medicine: Fallibility and Responsibility in Clinical Service. Cambridge University Press, Cambridge, 2003.
38. Denny, K. Evidence-based medicine and medical authority. J. Med. Humanit 20(4): 247-263, 1999.
39. Traynor, M. Purity, conversion and the evidence based movements. Health, 4(2): 139-158, 2000.
40. Sinclair, S. Evidence-based medicine: A new ritual in medical teaching. Brit. Med. Bull. 69(1):179-196, 2004.
41. Kristiansen, I. S., and Mooney, G. Evidence-based medicine: Method, collaboration, movement or crusade? In Evidence-Based Medicine: In Its Place, eds. I. S. Kristiansen and G. Mooney. Routledge, Abingdon, 2004.
42. The Evidence-Based Medicine Working Group. Evidence-based medicine: A new approach to teaching the practice of medicine. JAMA 268(17):2420-2425, 1992.
43. Pope, C. Resisting evidence: The study of evidence-based medicine as a contemporary social movement. Health 7(3):267-282, 2003.
44. Goldenberg, M. On evidence and evidence-based medicine: Lessons from the philosophy of science. Soc. Sci. Med. 62(11):2621-2632, 2006.
45. Charlton, B. Restoring the balance: Evidence-based medicine put in its place. J. Eval. Clin. Pract. 3(2):87-98, 1997.
46. Straus, S., and McAlister, F. Evidence-based medicine: A commentary on common criticisms. CMAJ 163(7):837-841, 2000.
47. Parker, M. False dichotomies: EBM, clinical freedom, and the art of medicine. Med. Humanit. 31(1):23-30, 2005.
48. Timmermans, S., and Kolker, E. Evidence-based medicine and the reconfiguration of medical knowledge. J. Health Soc. Behav. 45(Supp 1):177-193, 2004.
49. Nichol, K., et al. The effectiveness of vaccination against influenza in healthy, working adults. N. Engl. J. Med. 333(14):889-893, 1995.
50. Cooper, N., et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: Systematic review and meta-analyses of randomised controlled trials. BMJ 326(7401):1235-1238, 2003.
51. Palmore, J. A clear and present danger to international security: Highly pathogenic avian influenza. Def. Secur. Anal. 22(2):111-121, 2006.
52. Enemark, C. Is pandemic flu a security threat? Survival 51(1):191-214, 2009.
53. Vance, M. Disease mongering and the fear of pandemic influenza. Int. J. Health Serv. 41(1):95-115, 2011.
54. Fauci, A. S. Emerging and re-emerging infectious diseases: Influenza as a prototype of the host-pathogen balancing act. Cell 124(4):665-670, 2006.
55. Sargent, M. Who's afraid of biomedicine? Insights, fears, risks and opportunities. Interdisc. Sci. Rev. 30(3):257-272, 2005.
56. Barondess, J. Care of the medical ethos: Reflections on social Darwinism, racial hygiene, and the Holocaust. Ann. Int. Med. 129(11):891-898, 1998.
57. Pecoul, B., et al. Access to essential drugs in poor countries: A lost battle? JAMA 281(4):361-367, 1999.
58. Haas, E. B. When Knowledge Is Power: Three Models of Change in International Organizations. University of California Press, London, 1990.
59. Boswell, C. The Political Uses of Expert Knowledge: Immigration Policy and Social Research. Cambridge University Press, Cambridge, 2009.
60. Laver, G. Influenza drug could abort a pandemic. Nature 434(7035):821, 2005.
61. Kelso, J., Milne, G., and Kelly, H. Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza. BMC Public Health 9(Suppl. 1):117, 2009. www.biomedcentral.com/1471-2458/9/117 (accessed February 25, 2011).
62. UNSIC and World Bank. Responses to Avian Influenza and State of Pandemic Readiness. Third Global Progress Report. December 2007. United Nations System Influenza Coordinator, New York, 2007.
63. World Health Organization. WHO Checklist for Influenza Pandemic Preparedness Planning. Geneva, 2005.
64. Fedson, D. Preparing for pandemic vaccination: An international policy agenda for vaccine development. J. Public Health Policy 26(1):4-29, 2005.
65. Lett, D. WHO's call for international pandemic action unheeded. CMAJ 172(11):1429, 2005.
66. Osterholm, M. Preparing for the next pandemic. N. Engl. J. Med. 352(18):1839-1842, 2005.
67. Fidler, D. Negotiating equitable access to influenza vaccines: Global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1. PLoS Med. 7(5):1-4, 2010.
68. Supari, S. It's Time for the World to Change: In the spirit of dignity, equity, and transparency. Divine Hand Behind Avian Influenza. P. T. Sulaksana Watinsa Indonesia, Jakarta, 2008.
69. Fedson, D. Meeting the challenge of influenza pandemic preparedness in developing countries. Emerg. Infect. Dis. 15(3):365-371, 2009.
70. Oshitani, H., Kamigaki, T., and Suzuki, A. Major issues and challenges of influenza pandemic preparedness in developing countries. Emerg. Infect. Dis. 14(6):875-880, 2008.
71. Jones, J., and Salathé, M. Early assessment of anxiety and behavioral response to Novel Swine-Origin Influenza A (H1N1). PLoS ONE 4(12), 2009, e8032. doi: 10.1371/journal.pone.0008032.
72. Public Health Agency of Canada. News Conference with Minister of Health and Chief Public Health Officer, September 25, 2009. www.phac-aspc.gc.ca/alert- alerte/h1n1/conferences/nc-2009-09-25-eng.php (accessed March 1, 2011).
73. Cohen, J., and Enserink, M. As swine flu circles globe, scientists grapple with basic questions. Science 324(5927):572-573, 2009.
74. Collin, N., Radiguès, X., and World Health Organization. H1N1 Vaccine Task Force. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 27(38):5184-5186, 2009.
75. Fraser, C., et al. Pandemic potential of a strain of influenza A (H1N1): Early findings. Science 324(5934):1557-1561, 2009.
76. Gallaher, W. Towards a sane and rational approach to management of Influenza H1N1 2009. Virol. J. 6(51), 2009. doi: 10.1186/1743-422X-6-51.